Skip to content
Trial Eligibility
Menu

Duloxetine Metabolism and Fibromyalgia

NCT06866444

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

People with fibromyalgia report generalized body pain ("pain all over"), increased sensitivity to painful stimulation, chronic tiredness or low energy, sleep problems, and other physical and functional problems. The exact cause of the disorder is poorly understood, and treatment can be difficult. The degree to which duloxetine is helpful for people with fibromyalgia varies greatly. For some people, it is very helpful for managing fibromyalgia symptoms. For others, people may not notice any benefit.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Fibromyalgia
  • Duloxetine

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Utah
Last updated on ClinicalTrials.gov
September 25, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Utah · 1

  • Pain Management Center and Pain Research Center at the University of Utah · Salt Lake City, UT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.